Literature DB >> 22753195

Epidemiological evidence of a relationship between type-1 diabetes mellitus and cancer: a review of the existing literature.

Vanessa L Z Gordon-Dseagu1, Nicola Shelton, Jennifer S Mindell.   

Abstract

This review explores the epidemiological evidence relating to type-1 diabetes (T1DM) and cancer incidence and mortality. Mortality rates among those with T1DM are higher in every age group compared with the general population; the majority of this mortality is due to factors related to the consequences of diabetes, such as cardiovascular and renal disease. For over 100 years, researchers have explored the relationships between diabetes and cancer and although there is now a large body of work on the subject, consensus has not been reached. Such research has tended to focus upon type-2 diabetes, with the result that very little is known about T1DM and cancer. As incidence of T1DM increases, by around 3% annually among children, the need for further research into its impact upon cancer incidence and mortality increases. Within this review, findings varied by study method utilised, T1DM definition used and study region and outcome measure explored. None of the case-control studies found a statistically significant link between the two diseases, whereas both of the meta-analyses did. Cohort studies produced mixed results. There were also mixed findings among research that defined T1DM in the same way (e.g. defining individuals with the disease as those diagnosed with diabetes before 30 years of age). The review found a number of studies which explored cause-specific cancer mortality among those with diabetes; such studies also had mixed findings. This inconsistency within results suggests the need for further research to understand better the potential relationships between T1DM and cancer.
Copyright © 2012 UICC.

Entities:  

Mesh:

Year:  2012        PMID: 22753195     DOI: 10.1002/ijc.27703

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

Review 1.  Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.

Authors:  Gadi Shlomai; Brian Neel; Derek LeRoith; Emily Jane Gallagher
Journal:  J Clin Oncol       Date:  2016-11-07       Impact factor: 44.544

Review 2.  A new perspective on mechanisms governing skeletal complications in type 1 diabetes.

Authors:  Zeynep Seref-Ferlengez; Sylvia O Suadicani; Mia M Thi
Journal:  Ann N Y Acad Sci       Date:  2016-08-29       Impact factor: 5.691

3.  Life expectancy of type 1 diabetic patients during 1997-2010: a national Australian registry-based cohort study.

Authors:  Lili Huo; Jessica L Harding; Anna Peeters; Jonathan E Shaw; Dianna J Magliano
Journal:  Diabetologia       Date:  2016-01-21       Impact factor: 10.122

Review 4.  Diabetes mellitus carries a risk of gastric cancer: a meta-analysis.

Authors:  Shouji Shimoyama
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

5.  Organ-based response to exercise in type 1 diabetes.

Authors:  Lisa Stehno-Bittel
Journal:  ISRN Endocrinol       Date:  2012-12-02

Review 6.  Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer.

Authors:  Emily J Gallagher; Derek LeRoith
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

Review 7.  Cancer biology in diabetes.

Authors:  Shi Sen; Yanzheng He; Daisuke Koya; Keizo Kanasaki
Journal:  J Diabetes Investig       Date:  2014-03-05       Impact factor: 4.232

Review 8.  Warburg Effect - a Consequence or the Cause of Carcinogenesis?

Authors:  Slobodan Devic
Journal:  J Cancer       Date:  2016-04-26       Impact factor: 4.207

9.  Diabetes and risk of cancer.

Authors:  Samy L Habib; Maciej Rojna
Journal:  ISRN Oncol       Date:  2013-02-07

10.  A Population-Based Cohort Study of All-Cause and Site-Specific Cancer Incidence Among Patients With Type 1 Diabetes Mellitus in Taiwan.

Authors:  Pei-Chun Hsu; Wei-Hung Lin; Te-Hui Kuo; Hui-Mei Lee; Chieh Kuo; Chung-Yi Li
Journal:  J Epidemiol       Date:  2015-07-25       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.